PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2172224
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2172224
Bioactive Glass market size was valued at US$ 880.5 Million in 2025, expanding at a CAGR of 7.6% from 2026 to 2033.
Bioactive glass refers to a glass composed of silica, calcium, phosphorus, and sodium oxides that adheres to bones and other biological materials. When such a material is added into the body, hydroxyapatite is formed via a mechanism that involves the growth and creation of chemical bonds. The bioactive glasses include fibers, microfilaments, and nanofibers. They are used in bone morphogenesis, tissue engineering, wound healing, and drug delivery systems. Moreover, the bioactive glasses have the properties of osteogenic and angiogenic; therefore, they facilitate the formation of blood vessels and osteoblast growth. Therefore, the substance helps in attaching various tissues according to their application.
Bioactive Glass Market- Market Dynamics
Rising Prevalence OF Orthopedic To DRIVE Market Growth
The rising prevalence of orthopedic disorders is driving growth in the Bioactive Glass market. The bioactive glass helps in the healing process since they make the bonding of the bone and tissue easier and help in the healing process. They are used in orthopedic implants and bone grafting. For instance, in January 2025, according to the research conducted by the Bone & Joint Open Org, there are 791,000 people in the country who have undergone at least one joint replacement surgery. It accounts for 8.4% of people who are above the age of 40 years. Later on, it has been established that 436,000 people have undergone hip replacement, 383,000 people have had knee replacement, and 34,000 people have had shoulder replacement surgery. These findings highlight the substantial prevalence of joint replacement and the growing need for orthopedic care.
The Global Bioactive Glass market is segmented on the basis of Type, Form, Application, Synthesis Process, End User, and Region.
45S5 Bioglass holds a significant share in the Bioactive Glass market because of its excellent bioactivity, bone-bonding properties, and wide applications in bone regeneration, tissue engineering, and medical implant coatings. In February 2025, researchers affiliated with the Otto Schott Institute of Materials Research and Geomateriaux published a study comparing 45S5 Bioglass, S53P4, and 13-93 bioactive glass compositions, examining their structural characteristics, ion release, and properties relevant to bone regeneration.
Bioactive Glass Market- Geographical Insights
Asia Pacific is witnessing strong growth in the Bioactive Glass market because of the developed infrastructure of the healthcare system and increasing demand for orthopedic and dental treatments. In April 2025, according to the study "India's Oral Health Outlook: Challenges, Economic Impact, and Need for Preventative Strategies," published in Frontiers in Dental Medicine (NIH Gov), the annual economic impact of oral diseases in India was estimated to be INR 613.2 billion (USD 7,300 million). As found out from the survey, 51.5% of all survey participants aged from 18 to 24 had been to the dentist, whereas only 22.2% of those aged over 75 had been to the dentist. There is a great difference in oral health service usage between the younger generation and the older one. Also, 44.7% of all survey participants brushed their teeth twice a day during the survey. It means that preventive measures had been insufficient in the case of these respondents. Therefore, there is a great need for dental treatment services in India.
The Bioactive Glass market includes players such as Matexcel, BioMin Technologies Limited, Pulpdent Corporation, Berkeley Advanced Biomaterials, Inc., and Biomatlante. The companies provide their bioactive glass material and new biomaterials used in the manufacturing of medical devices. In June 2025, BioMin launched Profluorid Varnish + BioMin in partnership with VOCO. Profluorid Varnish + BioMin is a dental varnish that makes use of the bioactive glass material of the company to remineralize enamel and desensitize teeth. Hence, the companies working in this market are keen to develop strategic alliances and innovative material variations to stay ahead of other players.
In May 2026, DePuy Synthes has signed an exclusive distribution agreement with CGBIO for the distribution of NOVOSIS, a bone graft substitute comprising a growth factor, in the USA, Canada, and Australia. This agreement is in connection with the development and commercialization of the product in spine, craniomaxillofacial, and trauma indications. The terms used by the company pertain to its bone graft technology.
In August 2025, NovaBone introduced Bioactive Pre-contoured Wedge (BPW), a completely synthetic and porous bioactive glass material intended for foot and ankle surgery, presented at the American Orthopaedic Foot & Ankle Society 2025 Annual Meeting for deformity correction and bone regeneration.
In March 2025, Pulpdent Corporation introduced internationally ACTIVA BioACTIVE Bulk Flow at the International Dental Show in Cologne, Germany, from March 25 to 29. The product is a bioactive dental restorative material.